ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 50 filers reported holding ALBIREO PHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,359,000 | -56.9% | 486,181 | -66.1% | 0.18% | -14.2% |
| Q3 2019 | $28,656,000 | +24.1% | 1,432,762 | +100.0% | 0.21% | -39.1% |
| Q2 2019 | $23,096,000 | +0.1% | 716,381 | 0.0% | 0.35% | -23.3% |
| Q1 2019 | $23,075,000 | +31.3% | 716,381 | 0.0% | 0.45% | +59.9% |
| Q4 2018 | $17,573,000 | -25.6% | 716,381 | 0.0% | 0.28% | -5.3% |
| Q3 2018 | $23,612,000 | -7.2% | 716,381 | 0.0% | 0.30% | -9.9% |
| Q2 2018 | $25,432,000 | +0.5% | 716,381 | -7.8% | 0.33% | -12.8% |
| Q1 2018 | $25,310,000 | +27.2% | 777,096 | 0.0% | 0.38% | +25.2% |
| Q4 2017 | $19,894,000 | +22.2% | 777,096 | 0.0% | 0.30% | +16.0% |
| Q3 2017 | $16,280,000 | +1.7% | 777,096 | 0.0% | 0.26% | +20.6% |
| Q2 2017 | $16,008,000 | -14.2% | 777,096 | 0.0% | 0.22% | -3.1% |
| Q1 2017 | $18,650,000 | +35.4% | 777,096 | 0.0% | 0.22% | +51.0% |
| Q4 2016 | $13,778,000 | – | 777,096 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
| Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
| Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
| BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
| SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
| Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
| Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
| Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
| HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |